Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-26

Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of dapsone in acne vulgaris completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED | Results posted: 2014-03-26